1. Home
  2. CHSCL vs VCEL Comparison

CHSCL vs VCEL Comparison

Compare CHSCL & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHSCL
  • VCEL
  • Stock Information
  • Founded
  • CHSCL N/A
  • VCEL 1989
  • Country
  • CHSCL United States
  • VCEL United States
  • Employees
  • CHSCL N/A
  • VCEL N/A
  • Industry
  • CHSCL Farming/Seeds/Milling
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CHSCL Industrials
  • VCEL Health Care
  • Exchange
  • CHSCL Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • CHSCL N/A
  • VCEL 2.1B
  • IPO Year
  • CHSCL N/A
  • VCEL 1997
  • Fundamental
  • Price
  • CHSCL $25.52
  • VCEL $40.28
  • Analyst Decision
  • CHSCL
  • VCEL Strong Buy
  • Analyst Count
  • CHSCL 0
  • VCEL 8
  • Target Price
  • CHSCL N/A
  • VCEL $62.00
  • AVG Volume (30 Days)
  • CHSCL N/A
  • VCEL 476.9K
  • Earning Date
  • CHSCL N/A
  • VCEL 07-31-2025
  • Dividend Yield
  • CHSCL N/A
  • VCEL N/A
  • EPS Growth
  • CHSCL N/A
  • VCEL 521.85
  • EPS
  • CHSCL N/A
  • VCEL 0.05
  • Revenue
  • CHSCL N/A
  • VCEL $238,541,000.00
  • Revenue This Year
  • CHSCL N/A
  • VCEL $23.03
  • Revenue Next Year
  • CHSCL N/A
  • VCEL $24.52
  • P/E Ratio
  • CHSCL N/A
  • VCEL $675.02
  • Revenue Growth
  • CHSCL N/A
  • VCEL 14.80
  • 52 Week Low
  • CHSCL N/A
  • VCEL $37.39
  • 52 Week High
  • CHSCL N/A
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • CHSCL 46.40
  • VCEL 42.08
  • Support Level
  • CHSCL $25.36
  • VCEL $39.39
  • Resistance Level
  • CHSCL $25.58
  • VCEL $42.61
  • Average True Range (ATR)
  • CHSCL 0.16
  • VCEL 1.61
  • MACD
  • CHSCL 0.02
  • VCEL -0.20
  • Stochastic Oscillator
  • CHSCL 68.75
  • VCEL 11.60

About CHSCL CHS Inc Class B Cumulative Redeemable Preferred Stock Series 4

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: